Cerebrospinal Fluid Glycoproteins in Schizophrenia
Abstract
A double-blind clinical and chemical study of 131 hospitalized psychotic patients, totally removed geographically from the center at which chemical analyses were performed, demonstrated an inverse relationship between the quantity of cerebrospinal fluid glycoprotein neuraminic acid and the severity of schizophrenia, with a high concordance between chemical levels, changes in clinical condition, and family history. In addition, changes in cerebrospinal fluid glycoprotein hexose were related inversely to clinical estimates of depression.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
